220 related articles for article (PubMed ID: 33611869)
1. Preferences of inflammatory arthritis patients for biological disease-modifying antirheumatic drugs in the first 100 days of the COVID-19 pandemic.
Kalyoncu U; Pehlivan Y; Akar S; Kaşifoğlu T; Kimyon G; Karadağ Ö; Dalkılıç HE; Ertenli Aİ; Kılıç L; Ersözlü D; Bes C; Emmungil H; Mercan R; Ediboğlu ED; Kanıtez N; Bilgin E; Çolak S; Koca SS; Gönüllü E; Küçükşahin O; Coşkun N; Yağız B; Kiraz S
Turk J Med Sci; 2021 Aug; 51(4):1615-1623. PubMed ID: 33611869
[TBL] [Abstract][Full Text] [Related]
2. Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.
Glintborg B; Jensen DV; Engel S; Terslev L; Pfeiffer Jensen M; Hendricks O; Ostergaard M; Horskjær Rasmussen S; Adelsten T; Colic A; Danebod K; Kildemand M; Loft AG; Munk HL; Pedersen JK; Østgård RD; Møller Sørensen C; Krogh NS; Agerbo J; Ziegler C; Hetland M
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33402443
[TBL] [Abstract][Full Text] [Related]
3. HLA-B27 did not protect against COVID-19 in patients with axial spondyloarthritis - data from the ReumaCov-Brasil Registry.
Mota GD; Marques CL; Ribeiro SL; Albuquerque C; Castro G; Fernandino D; Omura F; Ranzolin A; Resende G; Silva N; Souza M; Studart S; Xavier R; Yazbek M; Pinheiro MM
Adv Rheumatol; 2023 Nov; 63(1):56. PubMed ID: 38031143
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 in Patients with Systemic Inflammatory Diseases: Impact on Disease Activity.
Miledi S; Bouzid S; Fazaa A; Sallemi M; Bousaa H; Ben Abdelghani K; Laatar A
Curr Rheumatol Rev; 2023 Jun; 19(3):330-335. PubMed ID: 36650623
[TBL] [Abstract][Full Text] [Related]
5. Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience.
Migkos MP; Kaltsonoudis E; Pelechas E; Drossou V; Karagianni PG; Kavvadias A; Voulgari PV; Drosos AA
Rheumatol Int; 2021 May; 41(5):903-909. PubMed ID: 33655421
[TBL] [Abstract][Full Text] [Related]
6. Adherence of rheumatoid arthritis patients to biologic disease-modifying antirheumatic drugs: a cross-sectional study.
Mena-Vazquez N; Manrique-Arija S; Yunquera-Romero L; Ureña-Garnica I; Rojas-Gimenez M; Domic C; Jimenez-Nuñez FG; Fernandez-Nebro A
Rheumatol Int; 2017 Oct; 37(10):1709-1718. PubMed ID: 28631046
[TBL] [Abstract][Full Text] [Related]
7. Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis.
Ben Tekaya A; Mehmli T; Ben Sassi M; Teyeb Z; Bouden S; Rouached L; Mahmoud I; Dziri C; Abdelmoula L
Clin Rheumatol; 2023 Apr; 42(4):979-997. PubMed ID: 36462127
[TBL] [Abstract][Full Text] [Related]
8. Use of healthcare resources in a cohort of rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs or tofacitinib.
Machado-Alba JE; Machado-Duque ME; Gaviria-Mendoza A; Reyes JM; Gamboa NC
Clin Rheumatol; 2021 Apr; 40(4):1273-1281. PubMed ID: 32997316
[TBL] [Abstract][Full Text] [Related]
9. Low rates of biologic-free clinical disease activity index remission maintenance after biologic disease-modifying anti-rheumatic drug discontinuation while in remission in a Japanese multicentre rheumatoid arthritis registry.
Yoshida K; Kishimoto M; Radner H; Matsui K; Okada M; Saeki Y; Solomon DH; Tohma S
Rheumatology (Oxford); 2016 Feb; 55(2):286-90. PubMed ID: 26350484
[TBL] [Abstract][Full Text] [Related]
10. Physicians' Biological Drug Preference in Patients With Rheumatoid Arthritis and Spondyloarthritis With a History of Malignancy: Perspectives From the Treasure Database.
Tekgoz E; Colak S; Yardimci KG; Kucuksahin O; Cinar M; Yilmaz S; Kasifoglu T; Bes C; Yagiz B; Erden A; Kilic L; Kanitez NA; Ertenli AI; Coskun BN; Ediboglu ED; Mercan R; Kiraz S; Yazisiz V; Karadag O; Atagunduz P; Kalyoncu U
J Clin Rheumatol; 2022 Mar; 28(2):e318-e323. PubMed ID: 34014053
[TBL] [Abstract][Full Text] [Related]
11. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
[TBL] [Abstract][Full Text] [Related]
12. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
Kim G; Barner JC; Rascati K; Richards K
Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
[TBL] [Abstract][Full Text] [Related]
13. Discontinuation of biologic therapy in patients with rheumatoid arthritis and ankylosing spondylitis: analysis from multicenter cohort study.
Ouardi NE; Maghraoui AE; Djossou HJ; Taoubane L; Ghassem AM; Toufik H; Majjad A; Sadni S; Mounach A; Hmamouchi I; Abouqal R; Bahiri R; Allali F; Bouchti IE; Ghozlani I; Hassikou H; Harzy T; Ichchou L; Mkinsi O; Niamane R; Bezza A
Rheumatol Int; 2023 Jan; 43(1):79-87. PubMed ID: 36334121
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registry.
Jørgensen TS; Kristensen LE; Christensen R; Bliddal H; Lorenzen T; Hansen MS; Østergaard M; Jensen J; Zanjani L; Laursen T; Butt S; Dam MY; Lindegaard HM; Espesen J; Hendricks O; Kumar P; Kincses A; Larsen LH; Andersen M; Næser EK; Jensen DV; Grydehøj J; Unger B; Dufour N; Sørensen V; Vildhøj S; Hansen IM; Raun J; Krogh NS; Hetland ML
Rheumatology (Oxford); 2015 Dec; 54(12):2156-65. PubMed ID: 26175471
[TBL] [Abstract][Full Text] [Related]
15. Adherence to biologic disease-modifying antirheumatic drugs in adult patients with rheumatic diseases.
Fazaa A; Makhlouf Y; Ben Ouhiba A; Miladi S; Sellami M; Ouenniche K; Souabni L; Kassab S; Chekili S; Zakraoui L; Ben Abdelghani K; Laatar A
Therapie; 2021; 76(5):467-474. PubMed ID: 32948325
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of rheumatoid arthritis in the Emilia Romagna region: a prospective population-based study.
Addimanda O; Marino M; Farina I; Trevisani M; Arrigoni E; Lumetti F; Crescentini F; Sambo P; Bezzi A; Bruschi M; Santilli D; Reta M; Bosi S; Delsante G; Girelli F; Montaguti L; Meliconi R; Sebastiani M; Ferri C; Malavolta N; Govoni M; Trombetti S; De Palma R; Salvarani C
Clin Exp Rheumatol; 2017; 35(2):201-208. PubMed ID: 28134078
[TBL] [Abstract][Full Text] [Related]
17. EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry.
Jørgensen TS; Turesson C; Kapetanovic M; Englund M; Turkiewicz A; Christensen R; Bliddal H; Geborek P; Kristensen LE
PLoS One; 2017; 12(2):e0169946. PubMed ID: 28151971
[TBL] [Abstract][Full Text] [Related]
18. Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry.
Prior-Español A; Sánchez-Piedra C; Campos J; Manero FJ; Pérez-García C; Bohórquez C; Busquets-Pérez N; Blanco-Madrigal JM; Díaz-Torne C; Sánchez-Alonso F; Mateo L; Holgado-Pérez S
Sci Rep; 2021 May; 11(1):11091. PubMed ID: 34045525
[TBL] [Abstract][Full Text] [Related]
19. Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational Study.
Michaud K; Pedro S; Wipfler K; Agarwal E; Katz P
Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1322-1331. PubMed ID: 33787086
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety of biologic agents between elderly-onset and young-onset RA patients: the ANSWER cohort study.
Jinno S; Onishi A; Dubreuil M; Akashi K; Hashimoto M; Yamamoto W; Murata K; Takeuchi T; Kotani T; Maeda Y; Ebina K; Son Y; Amuro H; Hara R; Katayama M; Saegusa J; Morinobu A
Rheumatol Int; 2020 Dec; 40(12):1987-1995. PubMed ID: 32728836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
